T
Terrence F. Blaschke
Researcher at Stanford University
Publications - 220
Citations - 17427
Terrence F. Blaschke is an academic researcher from Stanford University. The author has contributed to research in topics: Pharmacokinetics & Phenylephrine. The author has an hindex of 52, co-authored 217 publications receiving 16482 citations. Previous affiliations of Terrence F. Blaschke include University of California, San Francisco & VA Palo Alto Healthcare System.
Papers
More filters
Journal ArticleDOI
Adherence to Medication
TL;DR: Strategies to assess and enhance medication adherence (or compliance) are reviewed, to help patients adhere to prescribed treatment regimens and avoid stigmatization.
Journal ArticleDOI
Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction Its Role in Hypercholesterolemia
Rainer H. Böger,Stefanie M. Bode-Böger,Andrzej Szuba,Philip S. Tsao,Jason R. Chan,Oranee Tangphao,Terrence F. Blaschke,John P. Cooke +7 more
TL;DR: Elevation of ADMA is associated with impaired endothelium-dependent vasodilation and reduced urinary nitrate excretion and this abnormality is reversed by administration of L-arginine.
Journal ArticleDOI
Sex Differences in Pharmacokinetics and Pharmacodynamics
TL;DR: This review examines the biologic basis of differences in pharmacokinetics and pharmacodynamics between the sexes and summarizes studies that have addressed these differences.
Journal ArticleDOI
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.
Carl J. Fichtenbaum,John G. Gerber,Susan L. Rosenkranz,Yoninah Segal,Judith A. Aberg,Terrence F. Blaschke,Beverly Alston,Fang Fang,Bradley W. Kosel,Francesca T. Aweeka +9 more
TL;DR: SimVastatin should be avoided and atorvastatin may be used with caution in persons taking RTV and SQVsgc, and pravastatin does not alter the NFV pharmacokinetics, and thus appears to be safe for concomitant use.
Journal ArticleDOI
Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories.
TL;DR: Electronic methods for compiling drug dosing histories are now the recognized standard for quantifying adherence, the parameters of which support model-based, continuous projections of drug actions and concentrations in plasma that are confirmable by intermittent, direct measurements at single time points.